AquaBounty Technologies is a biotechnology company specializing in the development and commercialization of genetically enhanced aquaculture products. Its flagship offering, the AquaAdvantage Salmon, is an Atlantic salmon variant engineered to grow more rapidly than conventional farmed salmon, reducing the time from hatch to harvest. This innovation is designed to improve production efficiency and help meet global demand for seafood in a more sustainable manner.
Founded in 1991 and headquartered in Waltham, Massachusetts, AquaBounty has navigated a complex regulatory landscape to achieve full approvals for its AquaAdvantage Salmon in Canada, the United States and Panama. The company operates a state-of-the-art aquaculture facility in Indiana for land-based grow-out and maintains broodstock operations in Canada and Panama. These sites enable close oversight of the production cycle and stringent biosecurity measures, while complying with local and international food safety standards.
Beyond salmon, AquaBounty continues to explore advanced breeding techniques and biotechnologies aimed at other high-value aquaculture species. The company leverages proprietary genetic constructs and collaborates with academic institutions and industry partners to enhance growth rates, feed conversion efficiency and environmental footprint across its pipeline.
Under the leadership of President and Chief Executive Officer Ronald P. Stotish, AquaBounty’s management team combines expertise in molecular biology, aquaculture engineering and regulatory affairs. Their collective vision is to position the company at the forefront of sustainable seafood production by delivering innovative solutions that balance economic viability with ecological stewardship.
AI Generated. May Contain Errors.
Free AQB Stock Alerts